Mucosal melanoma is a neural-crest-derived neoplasm that originates in melanocytes and demonstrates melanocytic differentiation. Exposure to formalin and ultraviolet light are known etiologic factors; another possible factor is exposure to radiation. Approximately 15 to 20% of all skin melanomas develop on the head and neck, but less than 1% of all melanomas develop in ocular or mucosal sites, including the sinonasal tract.
provides the best outcome, although overall survival is poor and recurrences are common. Patients with obstructive symptoms, multiple sites of involvement, tumors of 3 cm or larger, an undifferentiated tumor on histology, a high mitotic count, and an elevated stage are more likely to have a poor prognosis.
Mucosal melanomas are frequently polypoid masses, growing as large as 6 cm, and they demonstrate surface erosion or ulceration. The color of melanin-producing tumors is generally black to dark brown. Histologically, these tumors have a protean architecture and cytology, and they frequently mimic other types of primary tumor. The presence of junctional activity and epidermal migration (Pagetoid spread) indicates that a patient has a primary tumor (figure 1). Destructive growth is common, and bone invasion, lymphovascular invasion, and perineural invasion are easily identified. Many different patterns of growth can be seen, including sheet-like, fascicular, organoid, storiform, and peritheliomatous; the peritheliomatous pattern is quite distinctive and unique to mucosal melanoma (figure 2). The cells may be polygonal, epithelioid, plasmacytoid, rhabdoid, or undifferentiated ( figure 3) . The nuclear chromatin is usually vesicular, with prominent, enlarged, irregular, and brightly hypereosinophilic nucleoli. Intranuclear cytoplasmic inclusions are also quite characteristic ( figure 3) .
The presence of melanin helps confirm the diagno- sis, but many tumors do not produce melanin. Tumor necrosis and increased mitoses, including atypical forms, are common. A melanin bleach (Fontana-Masson stain) can help confirm cytoplasmic melanin. Several immunohistochemical studies can be used to confirm melanoma, including S-100 protein, Sox10, HMB-45, melan-A, and tyrosinase. Because of the remarkable plasticity of the neoplastic cells, the histologic differential diagnosis includes olfactory neuroblastoma, sinonasal undifferentiated carcinoma, rhabdomyosarcoma, leiomyosarcoma, plasmacytoma, lymphoma, malignant peripheral nerve sheath tumor, and mesenchymal chondrosarcoma (the latter when the chondroid matrix is not seen). 
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